Progressive optic nerve collateralization after serial intravitreal ranibizumab injections for central retinal vein occlusion

Retina

Volumn 33, Issue 2, 2013, Pages 449-450

  Goldberg, Naomi ^a   Freund, K Bailey ^a,b  

^a VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB;

ADULT; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; COLLATERAL CIRCULATION; EYE PHOTOGRAPHY; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; MALE; OPHTHALMOSCOPY; OPTIC DISK; RECURRENT DISEASE; RETINA ANGIOGRAPHY; RETINA MACULA CYSTOID EDEMA; SHORT SURVEY; TREATMENT DURATION; VISUAL ACUITY; VISUAL IMPAIRMENT;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; HUMANS; HYPERCHOLESTEROLEMIA; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; OPTIC DISK; RETINAL VEIN OCCLUSION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84873408699     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3182733b83     Document Type: Short Survey

References (7)

1. Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: A prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc 1981;79: 371-422.
2. Hayreh SS. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res 2005;24:493-519.
3. Iturralde D, Spaide RF, Meyerle CB, et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: A short-term study. Retina 2006;26:279-284.
4. Wu L, Arevalo JF, Berrocal MH, et al. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: Results of the pan American collaborative retina study group at 24 months. Retina 2010;30:1002-1011.
5. Spaide RF, Chang LK, Klancnik JM, et al. Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion. Am J Ophthalmol 2009;147:298-306.
6. Ferrara D, Koizumi H, Spaide RF. Early bevacizumab treatment of central retinal vein occlusion. Am J Ophthalmol 2007;144:858-863.
7. Ameri H, Chader GJ, Kim JG, et al. The effects of intravitreous bevacizumab on retinal neovascular membrane and normal capillaries in rabbits. Invest Ophthalmol Vis Sci 2007;48: 5708-5715